Dabigatran etexilate: a new oral thrombin inhibitor

Circulation. 2011 Apr 5;123(13):1436-50. doi: 10.1161/CIRCULATIONAHA.110.004424.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Oral
  • Animals
  • Anticoagulants / administration & dosage
  • Anticoagulants / pharmacokinetics
  • Antithrombin Proteins / administration & dosage*
  • Antithrombin Proteins / pharmacokinetics
  • Benzimidazoles / administration & dosage*
  • Benzimidazoles / pharmacokinetics
  • Dabigatran
  • Humans
  • Prodrugs / administration & dosage*
  • Prodrugs / pharmacokinetics
  • Pyridines / administration & dosage*
  • Pyridines / pharmacokinetics
  • Randomized Controlled Trials as Topic / methods
  • Thrombin / antagonists & inhibitors*
  • Thrombin / metabolism
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / metabolism

Substances

  • Anticoagulants
  • Antithrombin Proteins
  • Benzimidazoles
  • Prodrugs
  • Pyridines
  • Thrombin
  • Dabigatran